29 January 2018: The Federal Ministers give a final decision (positive) for this trial
Trial reference:
A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects With Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases